纽约 - 专注于开发免疫调节疗法的生物科技公司Tiziana Life Sciences Ltd. (NASDAQ:TLSA)今天宣布,获得来自National Institutes of Health (NIH)的400万美元资助,用于研究鼻内给药foralumab(一种抗CD3单克隆抗体)治疗阿尔茨海默病的应用。该资助授予了Brigham and Women's Hospital的首席研究员H ...
Since the establishment of FOCAC, he said, China has helped Africa to build and upgrade almost 100,000 kilometers of roads, more than 10,000 kilometers of railways, nearly 1,000 bridges and almost 100 ...